Company
Axsome Therapeutics, Inc. (AXSM)
Standardized SEC financial data for Axsome Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001579428 · NASDAQ · Pharmaceutical Preparations.
Gross margin
92.6%
Operating margin
-26.1%
Net margin
-28.7%
Revenue growth (YoY)
65.5%
Return on equity
-207.5%
Free cash flow
-$93.9M
Debt / equity
2.13×
Current ratio
1.55×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $50.0M | $270.6M | $385.7M | $638.5M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $183.9M | $86.5M | $200.8M | $386.2M | $315.4M | $322.9M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$78.5M | -$108.2M | -$116.5M | -$145.1M | -$128.4M | -$93.4M |
| Capital expenditures |
Get AXSM data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AXSM/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AXSM/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"